These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4612276)

  • 1. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
    Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
    Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial treatment of acute myeloblastic leukemia with the cytosine arabinoside-cyclophosphamide association. (Apropos of 30 cases)].
    Bauters F; Lerche B; Samsoen J; Goudemand M
    Therapeutique; 1972 Apr; 48(4):303-8. PubMed ID: 4507025
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
    Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
    [No Abstract]   [Full Text] [Related]  

  • 5. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of acute leukemias].
    Jungi WF
    Schweiz Med Wochenschr; 1973 Sep; 103(38):1310-4. PubMed ID: 4519857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.
    Omura GA
    Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination chemotherapy of acute myeloblastic leukemias (author's transl)].
    Bauters F; Mouton J; Carrez J; Goudemand M
    Nouv Rev Fr Hematol; 1974; 14(5):653-62. PubMed ID: 4281478
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute granulocytic leukemia: treatment of the disease.
    Weil M; Jacyuillat CI; Gemon-Auclerc MF; Chastang CL; Izrael V; Boiron M; Bernard J
    Arch Intern Med; 1976 Dec; 136(12):1389-95. PubMed ID: 1069571
    [No Abstract]   [Full Text] [Related]  

  • 13. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of non-lymphoid acute leukemias].
    Mandelli F
    Minerva Med; 1975 Jul; 66(51):1546-52. PubMed ID: 1057048
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C; Inzoli MR
    G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute leukemias].
    Gross R; Gerecke D
    Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.